Volume 4,Issue 2
Objective: To explore the clinical efficacy and safety of tamsulosin combined with Huang’e capsules in treating type Ⅲ prostatitis. Methods: A total of 74 patients from the Department of Urology at Jiaxing University Affiliated Jiashan Hospital were selected and randomly divided into treatment group and control group by double-blind method, with 37 cases in each group. The treatment group was given tamsulosin combined with Huang’e capsules, and the control group was given tamsulosin alone. The NIH-CPSI, IIEF-5, and EPS-WBC scores and the incidence of adverse reactions in the two groups were compared before treatment as well as 15 and 30 days after treatment. Results: The treatment group showed statistically significant differences compared to the control group in terms of pain or discomfort, urinary symptoms, quality of life, NIH-CPSI, and EPS-WBC after treatment (P < 0.05). There was no statistically significant difference in IIEF-5 scores between the two groups (P > 0.05). No major adverse reactions occurred in either group during the treatment. Conclusion: Tamsulosin combined with Huang’e capsules can effectively improve the clinical symptoms of patients with type III prostatitis, enhance the quality of life, and has good safety.